Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs Intravenous Iron Therapy for Postpartum Anemia
NCT07340450Completed
- Sponsor
- Shahida Islam Medical Complex
- Start
- Feb 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ferric carboxymaltose in postpartum anemia (2 arms), sponsored by Shahida Islam Medical Complex. Primary endpoint: Change in hemoglobin level at 6 weeks. Started Feb 2025; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
postpartum anemia
Beyond the preview
Go deeper on NCT07340450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07340450.